Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
NAR Cancer|March 30, 2022
Epigenetic alterations at distal enhancers are linked to proliferation in human breast cancerJørgen Ankill, Miriam Ragle Aure, Sunniva Bjørklund, et al.
Breast Cancer (Dove Medical Press)|March 8, 2022
miR-101-5p Acts as a Tumor Suppressor in HER2-Positive Breast Cancer Cells and Improves Targeted TherapyLisa Svartdal Normann, Mads Haugland Haugen, Miriam Ragle Aure, et al.
Molecular Oncology|September 11, 2019
Identification of microRNAs involved in pathways which characterize the expression subtypes of NSCLCAnn Rita Halvorsen, Miriam Ragle Aure, Åsa Kristina Õjlert, et al.
Scientific Reports|May 26, 2021
MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitroLisa Svartdal Normann, Miriam Ragle Aure, Suvi-Katri Leivonen, et al.
Cell Reports|July 12, 2016
Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast CancerRobert Lesurf, Miriam Ragle Aure, Hanne Håberg Mørk, et al.
Nucleic Acids Research|December 8, 2022
Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of gene regulatory programs in cancersJaime A Castro-Mondragon, Miriam Ragle Aure, Ole Christian Lingjærde, et al.
Molecular Oncology|August 13, 2019
miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancerEvita Maria Lindholm, Miriam Ragle Aure, Mads Haugland Haugen, et al.
Plos Computational Biology|February 10, 2021
miRNA normalization enables joint analysis of several datasets to increase sensitivity and to reveal novel miRNAs differentially expressed in breast cancerShay Ben-Elazar, Miriam Ragle Aure, Kristin Jonsdottir, et al.
Molecular Oncology|February 17, 2015
MicroRNA let-7b regulates genomic balance by targeting Aurora B kinaseJenni Heidi Eveliina Mäki-Jouppila, Sofia Pruikkonen, Mahesh Balasaheb Tambe, et al.
Pageof 3